01-02-2002 | Commentary
COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients
Published in: Arthritis Research & Therapy | Issue 1/2002
Login to get access01-02-2002 | Commentary
Published in: Arthritis Research & Therapy | Issue 1/2002
Login to get access